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Introduction
Metabolic engineering is the genetic 
manipulation of intracellular, enzyme-
catalyzed, chemical reactions for the 
production of a desired molecule. For 
relatively simple products that require 
few gene manipulations to effect their 
production, natural or slightly modified 
control systems (such as promoters 
or ribosome-binding sites) have been 
widely used to control the expression 
of heterologous pathways or deregulate 
native genes. Most of these non-native 
controllers are static; that is, the level of 
gene expression is set without sensing 
changes in pathway output or cellular 
environment. Generally, these systems 
are optimized only for a particular envi-
ronment and any deviations away from 
that set of conditions are likely to result 
in suboptimal productivity.
Metabolic engineering is being called 
upon to tackle increasingly demanding 
challenges, like the production of com-
plicated pharmaceuticals and nutraceu-
ticals that require very long metabolic 
pathways or the convergence of multiple 
heterologous pathways. For example, the 
pathway from acetyl-CoA to β-carotene 
has been implemented with 12 enzy-
matic steps, and the production of the 
anti-malaria drug precursor artemisinic 
acid from acetyl-CoA uses 10 enzymatic 
steps (Yoon et al., 2009; Ro et al., 2006). 
As heterologous pathways become 
larger and more complicated, optimizing 
them becomes increasingly difficult such 
that piecewise optimizations, where a 
subset of the pathway is optimized at 
a time, are utilized (Martin et al., 2003). 
Because segments of pathways are not 
independent, performing pathway opti-
mization in sections and then combining 
the sections together can result in the 
final state of the cell being different from 
its state during the earlier optimizations. 
The ability to sense the output of each 
pathway segment and control of the lev-
els of expression of pathway enzymes 
(or activities of pathway enzymes) would 
allow each pathway segment to optimize 
itself relative to the other pathway seg-
ments and the cell’s native metabolism.
Another difficult, and timely, chal-
lenge in metabolic engineering is the 
production of molecules with a low profit 
margin (such as commodity chemicals 
and fuels), where the need to maximize 
yield and productivity are essential for 
economic viability (Zhang et al., 2008; 
Nakamura and Whited, 2003). The abil-
ity to sense critical metabolic intermedi-
ates and control levels of pathway gene 
expression could eliminate pathway bot-
tlenecks or the accumulation of poten-
tially toxic intermediates. Most of these 
molecules are produced by cells grown 
in large bioreactors where heterogene-
ities in the nutrient concentrations, oxy-
gen levels, or pH are often the norm and 
markedly different from the conditions 
under which the strains were originally 
constructed and optimized (that is, in 
the uniform environment of the shaker 
flask or small fermenter) (Amanullah et 
al., 2004; Schmidt, 2005). In applica-
tions such as these, the ability to sense 
the environment in which a particular 
cell finds itself and respond could vastly 
improve production by the entire cul-
ture. Additional improvements in yield 
or productivity could be achieved if the 
pathway has the capacity to monitor and 
respond to the cell’s growth phase and 
density.
In contrast to the static control engi-
neered into most heterologous path-
ways, native metabolic pathways gener-
ally utilize dynamic regulatory networks 
to compensate for changing conditions 
by altering fluxes. That is, the turn-
over rate of molecules by an enzyme is 
altered, often by allosteric inhibition or 
by a negative feedback loop regulating 
expression of the enzyme. As the envi-
ronment outside the cell changes (such 
as a change in nutrient availability or pH), 
the cell modulates its metabolic path-
ways dynamically to adjust fluxes so that 
required metabolic intermediates are 
delivered at the appropriate levels and 
times to optimize growth. Coupling sen-
sory inputs with control devices allows 
for pathways to be dynamically con-
trolled so that resources can be more 
efficiently utilized and productivity gains 
realized. By sensing cellular conditions 
and adjusting fluxes in a feedback loop, 
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the engineered cell can remain near the 
optimal productivity that corresponds to 
each set of conditions encountered.
The lack of dynamic controls in met-
abolic engineering is due in part to the 
complexity of designing and implement-
ing pathways that both sense the environ-
ment and control the formation of prod-
uct. Dynamic controls have the added 
requirements of a sensing component, a 
method of modulating flux, and a con-
nection between those two elements. An 
additional complexity of dynamic control 
is the requirement for more parameters 
to determine transient behavior than 
would be required for static behavior. 
Thus, the benefits of dynamic control 
may not be perceived to outweigh the 
additional time and money required for 
implementation and testing.
The predisposition against work-
ing on system dynamics is a problem 
that extends beyond synthetic biology. 
The majority of molecular biology and 
biomedical research also focuses on 
steady-state conditions, and this is likely 
due to the increased costs and difficultly 
of analyzing dynamic properties. Grow-
ing interest in implementing dynamic 
controls will result in the development 
of new experimental and computational 
procedures. These new techniques could 
lead to a synergy between synthetic biol-
ogy and molecular biology that rapidly 
advances research on dynamic systems. 
Recent work on the dynamics of native 
metabolic pathways demonstrates how 
molecular biology can provide insights 
into how to measure and optimize their 
responses (Chin et al., 2008).
Although there are barriers to the 
adoption of dynamic controls, advances 
in synthetic and systems biology will 
continue to lower these barriers and 
make dynamic controls more attrac-
tive. In particular, progress in modeling, 
computer-aided design, quantitative 
gene expression, and DNA synthesis 
and assembly will play important roles 
in enabling dynamic controls. And the 
development of advanced biological 
devices (for example, logic gates, bi-sta-
ble switches, counters, and ring oscilla-
tors) has resulted in the availability of a 
large number of well-characterized bio-
logical components that can be used to 
construct dynamic controllers. Many of 
these devices make use of standardized 
parts or interfaces that simplify functional 
composition and allow for rapid reuse of 
devices in new contexts. Hopefully these 
community-driven standards will result 
in a lowering of the costs involved in 
building complex systems. Not only will 
these well-characterized and standard-
ized components aid the development of 
dynamic controls, they will also further 
static control systems, which are likely to 
be used extensively for controlling meta-
bolic pathways long into the future.
Static Controls
Static controllers of flux are genetically 
encoded components that play a role in 
determining the level of flux through a 
pathway but do not sense cellular con-
ditions and modulate the pathway flux 
based on the sensed information. There 
are many parameters that can be used to 
change the static control of a particular 
flux. Examples of such parameters are 
strength and type of constitutive pro-
moter, ribosome binding site strength, or 
copy number of the vector.
There is a vast literature on promot-
ers and transcription initiation. However, 
much of the application of promoters in 
metabolic engineering involves the use 
of natural or slightly modified, inducible 
promoters or constitutive promoters of 
different strengths. Precise quantitative 
data on promoter activities from relevant 
culture conditions are required for pre-
dicting gene expression levels to alter 
flux. Recently, there has been an effort 
to standardize a technique for measuring 
relative promoter strengths (Kelly et al., 
2009). In this method, the fluorescence 
level from green fluorescent protein from 
a standard reference plasmid is com-
pared to a plasmid with only the promoter 
changed. The ratio of the two expression 
levels is expected to remain constant if 
the measurements are repeated with a 
different host strain or growth condition. 
Therefore, if the fluorescence from the 
standard plasmid is measured under a 
unique set of conditions, then the tran-
scription rate can be predicted for any 
promoter that has been previously mea-
sured in another context along with the 
reference promoter.
One major challenge in specifying 
the level of gene expression is design-
ing the appropriate levels of translation. 
In native systems, the folding of mRNA 
near the ribosome-binding site (RBS) 
can strongly contribute to the gene 
expression level. Because the portion of 
the mRNA containing the RBS can inter-
act with the gene-coding region, it is not 
trivial to predict how an RBS-gene pair 
will express based on their individual 
behavior in other contexts. The energet-
ics of translation initiation in prokaryotes 
has been extensively studied. However, 
many of the existing models have an 
unacceptable failure rate or are diffi-
cult to use when designing systems. A 
thermodynamic model of translation ini-
tiation has been developed by Salis et 
al. (2009) to predict the relative level of 
translation initiation for a given mRNA. 
Using the nucleotide sequence of a gene 
and a relative translation initiation rate, 
the algorithm generates a correspond-
ing RBS sequence that when incorpo-
rated into the construct will provide the 
desired level of gene expression. Use 
of such a tool reduces the unintentional 
introduction of inhibitory RNA secondary 
structures and allows for levels of gene 
expression to be easily and predictably 
adjusted.
Another method of achieving predict-
able translation levels is to use bicis-
tronic operons, which have long been 
employed to ensure high levels of expres-
sion from arbitrary genes (Schoner et al., 
1986). The existence of mRNA second-
ary structure between the second RBS 
and downstream gene does not cause 
translational inhibition, and therefore the 
translation initiation of the second gene 
is independent of its coding sequence 
(Kimura et al., 2005). The first gene can 
be a truncated protein that only exists to 
affect the translation of the second gene. 
Use of synthetic bicistronic systems has 
been limited to achieving high protein 
levels. However, there is the potential to 
create libraries of bicistronic static con-
trollers of flux that cover a broad range of 
translation initiation rates. It has not yet 
been demonstrated that bicistronic con-
structs can give predictable and precise 
expression of the second gene; however 
they are likely to outperform pairings of 
genes with independently characterized 
RBSs.
Increasing enzyme expression levels 
is an easy route to achieving high fluxes 
with static controls; however, other 
methods may make more efficient use of 
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cellular resources. By localizing tagged 
pathway enzymes to a scaffold using 
protein-protein interaction domains, 
Dueber et al. (2009) have been able to 
increase the flux 77-fold through a bio-
synthetic pathway for mevalonate in the 
bacterium Escherichia coli. They use an 
engineered scaffold, containing mouse 
and rat protein-protein interaction 
domains, to increase the local concen-
tration of the enzymes and prevent the 
accumulation of pathway intermediates 
that may be harmful to the cells.
Ideally, one would use a model to 
specify the gene expression levels 
needed to achieve the desired flux in 
any one particular reaction. The exis-
tence of genome-scale metabolic mod-
els has lead to the development of new 
computational algorithms for improving 
production strains. Microbes appear to 
maximize their formation of biomass, 
which often does not lead to high yields 
of the desired product. By altering or 
eliminating expression levels of native 
genes it is possible to improve a strain’s 
yield or productivity. However, the num-
ber of possible combinatorial changes 
is too large to test in vivo and therefore 
in silico methods are used to predict the 
best set of modifications. These predic-
tions are generally made using flux bal-
ance analysis, which makes an assump-
tion of steady-state conditions in order 
to reduce computational complexity 
(Llaneras and Picó, 2008).
Because flux balance analysis does 
not incorporate any regulatory informa-
tion, these methods can only suggest 
changes to expression levels of catalytic 
enzymes but not to regulatory genes. 
Another drawback of flux balance analy-
sis is the absence of any kinetic infor-
mation. Despite these short-comings, 
flux balance analysis has proven to be a 
useful tool for choosing where to imple-
ment static controllers of flux. Several 
algorithms have been published for 
determining targets for altered expres-
sion levels. To simplify calculations some 
methods only determine genes to be 
knocked out. The OptKnock framework 
uses linear programming techniques to 
efficiently find combinations of knock-
out candidates (Burgard et al., 2003). 
OptReg, an extension of the OptKnock 
framework, can select genes that should 
be expressed at higher levels, lower lev-
els, or not at all (Pharkya and Maranas, 
2006).
An alternative iterative search meth-
odology was used by Alper et al. (2005a) 
for optimizing lycopene biosynthesis 
in E. coli. They first identified advanta-
geous single knockouts and then addi-
tional knockouts were introduced in the 
single knockout strains, which were then 
tested for lycopene production. Strains 
with single, double, and triple knockouts 
Figure 1. Dynamic Control of a Synthetic Pathway
A dynamic controller of flux can achieve higher productivity than constitutive expression of the proteins in the pathway. The dynamic system only expresses the 
proteins involved in the production pathway once a threshold cell density is reached. 
(A) All dynamic controllers of flux contain a sensor, an output, and an interface between them. 
(B) At low cell densities the diffusible molecule acyl-homoserine lactone produced by LuxI is too dilute to activate its receptor LuxR. 
(C) Once a critical cell density is reached LuxR is activated and turns on expression of the pathway genes from the Lux promoter (Plux). 
(D) Plots showing how higher productivity can be obtained by delaying expression of the pathway until a high cell density is reached.
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were created and tested in vivo (Alper 
et al., 2005a). For most strains they find 
good agreement between in silico and in 
vivo results. To explore the limits of flux 
balance analysis, Alper et al. performed 
a global transposon search, which found 
new knockout targets, and used a conve-
nient screening method based on colony 
color to rapidly locate the advantageous 
knockouts. Although the transposon 
knockouts were able to improve produc-
tion, they did not exceed the produc-
tion of the best strain from flux balance 
analysis, nor did the combination of both 
knockout pools result in a new maximum 
level of lycopene production (Alper et al., 
2005b). This illustrates that developing 
in silico methods for determining which 
regulatory genes are good targets for 
knockouts or modification of expression 
level is an open area of research.
Dynamic Control
Dynamic control is a common feature of 
native metabolic pathways, and allosteric 
regulation is an important mechanism to 
maintain flux or limit accumulation of a 
metabolic intermediate through the path-
way in the face of changing conditions. In 
general, the first enzyme or a key branch-
point of a pathway is downregulated by 
the pathway’s product. For example, the 
first enzyme in E. coli’s serine biosyn-
thesis pathway, D-3-phosphoglycerate 
dehydrogenase (SerA), is allosterically 
inhibited by serine (Grant et al., 1996). 
There are few published examples of 
engineered dynamic control of fluxes in 
heterologous pathways. However, these 
systems will become increasingly com-
mon as engineered networks become 
more predictable (Figure 1).
Farmer and Liao (2000) were the first 
to demonstrate that engineering dynamic 
control of fluxes could improve yield and 
productivity of a heterologous pathway. 
Excess glucose flux and the diversion of 
carbon to acetate formation reduce the 
productivity of lycopene-generating E. 
coli cultures. An acetyl phosphate-acti-
vated transcription factor and promoter 
were used as a sensor of excess glucose 
flux. When acetyl phosphate accumu-
lates inside the cell and is detected by 
the engineered system, transcription of 
two genes regulated by the engineered 
system (pps and idi) are upregulated, 
which diverts flux from acetate produc-
tion to lycopene. The strain with dynamic 
control of pps and idi produces titers of 
lycopene that are 18-fold higher (and 
comparable improvement to productiv-
ity) than those from a strain with consti-
tutive control of the genes.
Growing cultures to an intermediate 
or high density before inducing product 
formation is a common practice because 
it can greatly improve productivity. How-
ever using inducer adds cost and poten-
tial regulatory hurdles. An alternative is 
to engineer microbes to sense their own 
density and activate gene expression at 
the appropriate time (Kobayashi et al., 
2004). By linking a genetic toggle switch 
to a synthetic quorum sensing system 
based on the lux system from Vibrio 
fischeri, cells activate gene expression 
when they reach a threshold density 
(Kobayashi et al., 2004). At low cell den-
sities the protein of interest is not detect-
able, at intermediate densities there is a 
bimodal distribution with the majority of 
cells not expressing the protein, and at 
high densities all the cells express the 
protein. Although this system has been 
used in the context of protein production, 
it could easily be applied to metabolic 
engineering to upregulate an enzyme or 
pathway.
More recently, Gadkar et al. (2005) 
have shown that it is possible to use met-
abolic flux analysis to predict improve-
ments in product formation resulting 
from dynamic pathway control. Using a 
metabolic model of a glycerol-producing 
strain of E. coli, the optimal induction 
time for the glycerol kinase gene, glpK, 
was determined so that growth is maxi-
mized in one phase and production max-
imized in the other phase. Introducing 
this level of dynamic control of enzyme 
expression increased biomass, leading 
to higher glycerol productivity.
The same modeling framework has 
also been applied to ethanol production 
by an E. coli strain deficient in the lactate 
biosynthetic enzyme lactate dehydro-
genase and expressing a heterologous 
pyruvate decarboxylase and alcohol 
dehydrogenase (Gadkar et al., 2005). 
Knocking out the gene encoding acetate 
kinase, ackA, is known to drastically 
decrease the growth rate but increase 
the flux of carbon to ethanol production. 
The authors compared an ackA knock-
out to the repression of ackA expres-
sion at an optimal time during the pro-
cess. The general results are similar to 
those revealed for glycerol production; a 
higher initial growth rate allows the cul-
ture with a modulated ackA to have an 
increased productivity in experiments 
of limited duration. This work provides a 
mathematical framework for dynamically 
controlling fluxes and demonstrates the 
advantages of doing so.
Anesiadis et al. (2008) assessed in 
silico the ability of the dynamic control-
ler devised by Kobayashi et al. (2004) to 
modulate fluxes in strains engineered 
to produce ethanol or succinate. In all 
cases, Anesiadis et al. had the dynamic 
controller repress expression of one or 
more genes when cell density reached a 
threshold. The affinity between LuxR (a 
quorum sensing transcriptional activator) 
and its ligand acyl-homoserine lactone is 
used to tune the threshold cell density. 
The modulated genes were in compet-
ing pathways or consumed an upstream 
metabolite. With an in silico genome-
scale model of E. coli, the authors dem-
onstrate that a self-regulating biphasic 
culture could be obtained and that such 
a culture could result in increased pro-
ductivity.
Opportunities for Dynamic Controls
The literature on dynamic control that 
we have presented provides examples 
of added layers of regulation that could 
be integrated with existing heterologous 
pathways to turn on or off genes at cer-
tain stages of the culture. This is a pow-
erful paradigm and for the near term will 
likely constitute the majority of research 
on dynamic controls. However there are 
other ways of applying dynamic controls 
to metabolic engineering that have not 
yet been demonstrated.
Mimicking allosteric regulation is dif-
ficult to implement for an arbitrary prod-
uct, in part because protein engineer-
ing is not yet sophisticated enough to 
perform such a task. However it would 
be easier to implement a feedback loop 
that modulates the expression level of 
an upstream enzyme. An engineered 
aptazyme (a fusion of an aptamer and 
ribozyme to form an allosteric catalytic 
RNA) could be used to sense product 
and accordingly inhibit translation of an 
enzyme in its metabolic pathway. Alter-
natively, the dynamic control could forgo 
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sensing the product and simply attempt 
to maintain an enzyme at a constant con-
centration by creating a fusion between 
the enzyme and a transcriptional inhibi-
tor so that the enzyme autoregulates its 
own transcription. Such a feedback loop 
could reduce the noise present in gene 
expression to give a more constant level 
of enzyme (Becskei and Serrano, 2000).
One opportunity is to engineer dynamic 
controls that will respond to cell hetero-
geneities and “dead zones” present in 
large-scale industrial cultures. Through 
scale up, it can be difficult to maintain a 
homogeneous culture in part due to gra-
dients of carbon source, O2, pH, or CO2 in 
large fermentation vessels (Amanullah et 
al., 2004). Strains with only static control 
of flux through the heterologous pathway 
cannot be optimized for production in all 
of these different environments. By using 
dynamic controls it may be possible to 
partially rescue the productivity of cells 
while they are in the undermixed regions 
of the bioreactor. This is a challenging 
proposition because time constants of 
the dynamic controls will need to be less 
than the circulation time of cells in the 
bioreactor.
One final application for dynamic 
controls is to enable piecewise optimi-
zation of a large pathway. If a strain is 
designed and optimized to produce a 
common precursor, then later work to 
add more genes downstream has the 
potential to interact with the upstream 
portion of the pathway and perturb it 
away from the optimal flux. A system 
that could sense and respond to the 
change in flux would allow downstream 
engineering to proceed with less con-
cern about how additions to the strain 
might negate previous work.
Conclusions
Synthetic biology has the potential to 
reshape how heterologous pathways are 
designed and controlled. Static controls 
for synthetic pathways are becoming 
more predictable, and in combination 
with advances in DNA synthesis, new 
levels of complexity in pathway design 
are now feasible. This additional com-
plexity can enable new, longer path-
ways or can be used to add dynamic 
controls that can increase productivity 
and make strains more robust to chang-
ing conditions.
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